Abstract 5655
Background
Although the TOGA study used cisplatin plus capecitabine (XP) or fluorouracil (FP), oxaliplatin schedules (CAPOX or FOLFOX) are commonly used. There is also a discrepancy in the no. of cycles and the maintenance treatment with trastuzumab (T).
Methods
We conducted an observational, retrospective, multicentric study of patients with metastatic HER2 GC or GEJ treated at 6 spanish hospitals belonging to Galician Research Group on Digestive Tumors (GITuD). Demographic, clinic and pathological data were retrospectively collected and correlated with overall survival (OS) and progression free survival (PFS).
Results
91 pts treated between May 2010 to January 2018 were recorded. Median age was 68 years (range 38-84 years), 74.7% were male, 39.6% GEJ location, 82.9% intestinal Lauren subtype, 64.5% well-moderate differentiated, 82.4% synchronous disease and 24.2% primary tumor resection. Median of metastatic locations was 2 (range 1-4). Chemotherapy backbone: FP 4.7%, XP 21.2%, CAPOX 37.6%, FOLFOX 36.5%. With a median follow up of 45.6 months, 85 pts were evaluable for efficacy. Median OS was 14.2 months (CI 95% 10.3-18.0 months) and median first line PFS was 8.9 months (CI 95% 7.7-10.1 months). Overall response rate 57.6% and disease control rate 78.8%. Median cycles of induction treatment were 6 (range 1-18). No PFS differences were found according to the platinum (p = 0.579) or fluropirimidine used (p = 0.955). Of 47 non-progressive patients after 6 months the majority received maintenance treatment for a median of 6.5 cycles (range2-77) with T +/- fluoropirimidine (21 and 16 pts) while 10 discontinued treatment. Post-induction PFS favors those who continued treatment with a PFS of 7.6 vs 5.0 months (p = 0.033), without differences between schemas (p = 0.890)). Primary tumor surgery (HR 0.380; p = 0.010), neutrophil to lymphocyte ratio < 5 (HR 0.461; p = 0.008), platelet to lymphocyte ratio <200 (HR 0.557; p = 0.030) were associated with prolonged OS.
Conclusions
Maintenance treatment with T has a benefit in terms of PFS even in patients who received T during induction. The practice of continuing the fluoropirimidine during maintenance doesńt appear to add any PFS benefit in our series.
Clinical trial identification
Legal entity responsible for the study
Galician Research Group on Digestive Tumors.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract